التفاصيل البيبلوغرافية
العنوان: |
Comparative real-world (RW) evidence on darolutamide (Daro), enzalutamide (Enza), and apalutamide (Apa) for patients (Pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) in the United States: DEAR. |
المؤلفون: |
Morgans, Alicia K., Shore, Neal D., Khan, Nasreen, Constantinovici, Niculae, Khan, Javeed, Chen, Guifang, Xu, Julie, Ortiz, Jorge A., George, Daniel J. |
المصدر: |
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p5097-5097, 1p |
قاعدة البيانات: |
Supplemental Index |